[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT05332054":3,"trial-entities:NCT05332054":324,"trial-summary:NCT05332054":331},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":16,"conditions":17,"keywords":28,"study_type":33,"primary_purpose":34,"phases":35,"enrollment_info":36,"interventions":39,"primary_outcomes":46,"secondary_outcomes":74,"sex":79,"minimum_age":80,"maximum_age":34,"healthy_volunteers":15,"eligibility_criteria":81,"std_ages":89,"locations":92,"central_contacts":320,"overall_officials":321,"references":322,"see_also_links":323},"NCT05332054","LTFS","Long-Term Follow-up Study","An Observational Long-Term Follow-up Study of Patients Who Received Prior Caribou Cell Therapy","ENROLLING_BY_INVITATION","2041-12","2026-03","2026-03-12","2022-03-16","Caribou Biosciences, Inc.","INDUSTRY",false,"This is an observational, non-interventional, LTFS of investigational Caribou therapies in patients who have participated in a parent study: a prior Caribou-sponsored clinical study, special access program, or an IIT. The objective is to evaluate the long-term safety, through 15 years post infusion, in patients who received IPs in a Caribou-sponsored clinical study, special access program or IIT.",[18,19,20,21,22,23,24,25,26,27],"Lymphoma, Non-Hodgkin","Relapsed Non-Hodgkin Lymphoma","Refractory B-Cell Non-Hodgkin Lymphoma","Non-Hodgkin Lymphoma","Lymphoma","B Cell Lymphoma","B-Cell Non-Hodgkin's Lymphoma","Hematologic Malignancy","Relapsed\u002FRefractory Multiple Myeloma","Relapsed\u002FRefractory Acute Myeloid Leukemia",[29,30,31,32],"Allogeneic CAR-T","CB-010","CB-011","CB-012","OBSERVATIONAL",null,[],{"count":37,"type":38},150,"ESTIMATED",[40],{"type":41,"name":42,"description":43,"armGroupLabels":44},"BIOLOGICAL","Caribou-sponsored investigational therapy","N\u002FA this is an observational study",[45],"Patients who received IP in a Caribou-sponsored, special access program or IIT and provided informed",[47,50,52,54,56,58,60,62,64,66,68,70,72],{"measure":48,"description":48,"timeFrame":49},"Incidence of targeted NSAEs","15 Years",{"measure":51,"description":51,"timeFrame":49},"Frequency of targeted NSAEs",{"measure":53,"description":53,"timeFrame":49},"Duration of targeted NSAEs",{"measure":55,"description":55,"timeFrame":49},"Outcome of targeted NSAEs",{"measure":57,"description":57,"timeFrame":49},"Incidence of AESIs",{"measure":59,"description":59,"timeFrame":49},"Frequency of AESIs",{"measure":61,"description":61,"timeFrame":49},"Duration of AESIs",{"measure":63,"description":63,"timeFrame":49},"Outcome of AESIs",{"measure":65,"description":65,"timeFrame":49},"Incidence of targeted SAEs",{"measure":67,"description":67,"timeFrame":49},"Frequency of targeted SAEs",{"measure":69,"description":69,"timeFrame":49},"Duration of targeted SAEs",{"measure":71,"description":71,"timeFrame":49},"Outcome of targeted SAEs",{"measure":73,"description":73,"timeFrame":49},"Incidence of AEs related to IP leading to death",[75],{"measure":76,"description":77,"timeFrame":78},"Overall survival","Assessment of overall survival and disease progression as described in the SOA","15 years","ALL","18 Years",{"inclusion":82,"exclusion":86,"raw_text":88},[83,84,85],"Written informed consent (by patient or legal representative) obtained prior to study-specific activities\u002Fenrollment","Completed a Caribou-sponsored study or was administered Caribou IP under a special access program or as part of an IIT","Use of an effective method of birth control by women of childbearing potential and their partners and men with partners of childbearing potential (partners must also use an effective birth control method) through 12 months post IP infusion.",[87],"None","Inclusion Criteria:\n\n* Written informed consent (by patient or legal representative) obtained prior to study-specific activities\u002Fenrollment\n* Completed a Caribou-sponsored study or was administered Caribou IP under a special access program or as part of an IIT\n* Use of an effective method of birth control by women of childbearing potential and their partners and men with partners of childbearing potential (partners must also use an effective birth control method) through 12 months post IP infusion.\n\nExclusion Criteria:\n\n* None",[90,91],"ADULT","OLDER_ADULT",[93,102,110,117,125,132,140,144,152,159,167,174,182,190,197,205,212,219,223,230,238,246,253,261,269,277,281,288,296,304,312],{"facility":94,"city":95,"state":96,"zip":97,"country":98,"geoPoint":99},"University of Alabama","Birmingham","Alabama","35233","United States",{"lat":100,"lon":101},33.52066,-86.80249,{"facility":103,"city":104,"state":105,"zip":106,"country":98,"geoPoint":107},"Banner MD Anderson Cancer Center","Gilbert","Arizona","85234",{"lat":108,"lon":109},33.35283,-111.78903,{"facility":111,"city":112,"state":105,"zip":113,"country":98,"geoPoint":114},"Honor Health Research Institute","Scottsdale","85258",{"lat":115,"lon":116},33.50921,-111.89903,{"facility":118,"city":119,"state":120,"zip":121,"country":98,"geoPoint":122},"University of California Irvine","Irvine","California","92868",{"lat":123,"lon":124},33.66946,-117.82311,{"facility":126,"city":127,"state":120,"zip":128,"country":98,"geoPoint":129},"University of California San Diego","La Jolla","92093",{"lat":130,"lon":131},32.84727,-117.2742,{"facility":133,"city":134,"state":135,"zip":136,"country":98,"geoPoint":137},"University of Colorado","Denver","Colorado","80045",{"lat":138,"lon":139},39.73915,-104.9847,{"facility":141,"city":134,"state":135,"zip":142,"country":98,"geoPoint":143},"Colorado Blood Cancer Institute","80218",{"lat":138,"lon":139},{"facility":145,"city":146,"state":147,"zip":148,"country":98,"geoPoint":149},"University of Miami","Miami","Florida","33136",{"lat":150,"lon":151},25.77427,-80.19366,{"facility":153,"city":154,"state":147,"zip":155,"country":98,"geoPoint":156},"AdventHealth Medical Group Blood & Marrow Transplant at Orlando","Orlando","32804",{"lat":157,"lon":158},28.53834,-81.37924,{"facility":160,"city":161,"state":162,"zip":163,"country":98,"geoPoint":164},"Blood & Marrow Transplant Group of Georgia","Atlanta","Georgia","30342",{"lat":165,"lon":166},33.749,-84.38798,{"facility":168,"city":169,"state":162,"zip":170,"country":98,"geoPoint":171},"Augusta University\u002FGeorgia Cancer Center","Augusta","30912",{"lat":172,"lon":173},33.47097,-81.97484,{"facility":175,"city":176,"state":177,"zip":178,"country":98,"geoPoint":179},"University of Iowa Hospitals & Clinics","Iowa City","Iowa","52242",{"lat":180,"lon":181},41.66113,-91.53017,{"facility":183,"city":184,"state":185,"zip":186,"country":98,"geoPoint":187},"University of Kentucky","Lexington","Kentucky","40536",{"lat":188,"lon":189},37.98869,-84.47772,{"facility":191,"city":192,"state":185,"zip":193,"country":98,"geoPoint":194},"Norton Cancer Institute","Louisville","40207",{"lat":195,"lon":196},38.25424,-85.75941,{"facility":198,"city":199,"state":200,"zip":201,"country":98,"geoPoint":202},"Regional Cancer Care Associates - Hackensack","Hackensack","New Jersey","07601",{"lat":203,"lon":204},40.88593,-74.04347,{"facility":206,"city":207,"state":200,"zip":208,"country":98,"geoPoint":209},"Atlantic Health System Cancer Care","Morristown","07960",{"lat":210,"lon":211},40.79677,-74.48154,{"facility":213,"city":214,"state":214,"zip":215,"country":98,"geoPoint":216},"Weill Cornell Medicine","New York","10021",{"lat":217,"lon":218},40.71427,-74.00597,{"facility":220,"city":214,"state":214,"zip":221,"country":98,"geoPoint":222},"Icahn School of Medicine at Mt. Sinai","10029",{"lat":217,"lon":218},{"facility":224,"city":225,"state":214,"zip":226,"country":98,"geoPoint":227},"Montefiore Medical Center","The Bronx","10467",{"lat":228,"lon":229},40.84985,-73.86641,{"facility":231,"city":232,"state":233,"zip":234,"country":98,"geoPoint":235},"Levine Cancer Center","Charlotte","North Carolina","28204",{"lat":236,"lon":237},35.22709,-80.84313,{"facility":239,"city":240,"state":241,"zip":242,"country":98,"geoPoint":243},"Oncology Hematology Care","Cincinnati","Ohio","45242",{"lat":244,"lon":245},39.12711,-84.51439,{"facility":247,"city":248,"state":241,"zip":249,"country":98,"geoPoint":250},"Cleveland Clinic","Cleveland","44195",{"lat":251,"lon":252},41.4995,-81.69541,{"facility":254,"city":255,"state":256,"zip":257,"country":98,"geoPoint":258},"University of Pennsylvania","Philadelphia","Pennsylvania","19104",{"lat":259,"lon":260},39.95238,-75.16362,{"facility":262,"city":263,"state":264,"zip":265,"country":98,"geoPoint":266},"Sarah Cannon Research Institute - TriStar Health","Nashville","Tennessee","37203",{"lat":267,"lon":268},36.16589,-86.78444,{"facility":270,"city":271,"state":272,"zip":273,"country":98,"geoPoint":274},"University of Texas Southwestern","Dallas","Texas","75235",{"lat":275,"lon":276},32.78306,-96.80667,{"facility":278,"city":271,"state":272,"zip":279,"country":98,"geoPoint":280},"Baylor Research Institute","75246",{"lat":275,"lon":276},{"facility":282,"city":283,"state":272,"zip":284,"country":98,"geoPoint":285},"MD Anderson Cancer Center","Houston","77030",{"lat":286,"lon":287},29.76328,-95.36327,{"facility":289,"city":290,"state":291,"zip":292,"country":98,"geoPoint":293},"Huntsman Cancer Institute at the University of Utah","Salt Lake City","Utah","84112",{"lat":294,"lon":295},40.76078,-111.89105,{"facility":297,"city":298,"state":299,"zip":300,"country":98,"geoPoint":301},"Virginia Commonwealth University","Richmond","Virginia","23284",{"lat":302,"lon":303},37.55376,-77.46026,{"facility":305,"city":306,"state":307,"zip":308,"country":98,"geoPoint":309},"Fred Hutchinson Cancer Center","Seattle","Washington","98109",{"lat":310,"lon":311},47.60621,-122.33207,{"facility":313,"city":314,"state":315,"zip":316,"country":98,"geoPoint":317},"Medical College of Wisconsin","Milwaukee","Wisconsin","53226",{"lat":318,"lon":319},43.0389,-87.90647,[],[],[],[],{"nct_id":4,"conditions":325,"biomarkers":330},[326,327,328,329],"Acute Myeloid Leukemia","B-Cell Non-Hodgkin Lymphoma","Malignant neoplasm of lymphoid, hematopoietic and\u002For related tissue","Multiple Myeloma",[],{"nct_id":4,"found":15,"summary":34,"prompt_version":34}]